PL1993365T3 - Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem - Google Patents
Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiemInfo
- Publication number
- PL1993365T3 PL1993365T3 PL07752521T PL07752521T PL1993365T3 PL 1993365 T3 PL1993365 T3 PL 1993365T3 PL 07752521 T PL07752521 T PL 07752521T PL 07752521 T PL07752521 T PL 07752521T PL 1993365 T3 PL1993365 T3 PL 1993365T3
- Authority
- PL
- Poland
- Prior art keywords
- bioavailable
- age
- disease
- related disorders
- treating alzheimer
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 229930153442 Curcuminoid Natural products 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77981706P | 2006-03-06 | 2006-03-06 | |
| EP07752521.0A EP1993365B1 (en) | 2006-03-06 | 2007-03-06 | Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders |
| PCT/US2007/005829 WO2007103435A2 (en) | 2006-03-06 | 2007-03-06 | Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1993365T3 true PL1993365T3 (pl) | 2013-10-31 |
Family
ID=38475534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07752521T PL1993365T3 (pl) | 2006-03-06 | 2007-03-06 | Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9192644B2 (pl) |
| EP (1) | EP1993365B1 (pl) |
| ES (1) | ES2427216T3 (pl) |
| PL (1) | PL1993365T3 (pl) |
| WO (1) | WO2007103435A2 (pl) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2644093A1 (en) * | 2006-03-17 | 2007-09-27 | Herbalscience Singapore Pte. Ltd. | Extracts and methods comprising curcuma species |
| BRPI0709409A2 (pt) | 2006-03-28 | 2011-07-12 | Javelin Pharmaceuticals Inc | composição farmacêutica e método para tratar um mamìfero necessitando de analgesia |
| EP2294049A4 (en) * | 2008-07-07 | 2011-06-22 | Laila Pharmaceuticals Pvt Ltd | ORAL ACTIVE CURCUMINOID COMPOUNDS |
| US9700525B2 (en) | 2008-08-20 | 2017-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders |
| US20110212142A1 (en) * | 2008-11-17 | 2011-09-01 | Laila Pharmaceuticals Pvt.Ltd. | Curcuminoids and its metabolites for the application in ocular diseases |
| CA2746273C (en) * | 2008-12-11 | 2019-04-09 | Human Biomolecular Research Institute | Small molecule immunomodulators for alzheimer's disease |
| EP2408442B1 (en) * | 2009-03-20 | 2016-08-17 | Bioxtract S.A. | Pharmaceutical composition presenting anti-inflammatory properties |
| US9393198B2 (en) * | 2010-03-22 | 2016-07-19 | Signpath Pharma Inc. | Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| CA2808710A1 (en) * | 2010-08-18 | 2012-02-23 | Clearfarma Industries Ltd. | Functional food compositions and methods |
| US9474727B2 (en) | 2010-09-15 | 2016-10-25 | Cadila Pharmaceuticals Limited | Pharmaceutical compositions of curcumin |
| BR112013008737A2 (pt) * | 2010-10-14 | 2015-09-01 | Abbott Gmbh & Co Kg | Formulação de dispersão sólida de curcuminóide |
| US9345683B2 (en) | 2010-11-08 | 2016-05-24 | Cadila Pharmaceuticals Limited | Pharmaceutical composition of taxoids |
| US8785380B2 (en) | 2011-02-01 | 2014-07-22 | M/S Akay Flavours & Aromatics Pvt Ltd. | Formulation containing curcuminoids exhibiting enhanced bioavailability |
| WO2012156979A1 (en) | 2011-05-16 | 2012-11-22 | Omniactive Health Technologies Ltd | A water soluble composition comprising curcumin having enhanced bioavailability and process thereof |
| GB2507884B (en) | 2011-06-03 | 2019-10-23 | Signpath Pharma Inc | Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current |
| US10238602B2 (en) | 2011-06-03 | 2019-03-26 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies |
| US10449193B2 (en) | 2011-06-03 | 2019-10-22 | Signpath Pharma Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies |
| US12004868B2 (en) | 2011-06-03 | 2024-06-11 | Signpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel |
| US10117881B2 (en) | 2011-06-03 | 2018-11-06 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies |
| US10349884B2 (en) | 2011-06-03 | 2019-07-16 | Sighpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| CN102274163B (zh) * | 2011-08-12 | 2013-01-02 | 山东大学 | 一种姜黄素纳米胶束制剂及其制备方法 |
| WO2013086330A1 (en) * | 2011-12-08 | 2013-06-13 | Abbott Laboratories | Nutritional compositions comprising curcumin and docosahexaenoic acid for improving cognition |
| EP2804587B1 (en) | 2012-01-19 | 2019-05-08 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Formulation and method for increasing oral bioavailability of drugs |
| US20150104503A1 (en) * | 2012-05-22 | 2015-04-16 | Harold Gordon Cave | Complexes and compositions containing curcumin |
| EP2861982A4 (en) * | 2012-06-14 | 2016-02-17 | Signpath Pharma Inc | METHOD AND SYSTEM FOR MEASURING THE PHARMACOKINETICS OF LIPOSOMAL CURCUMINE AND ITS METABOLITE TETRAHYDROCURCUMINE |
| US9138411B2 (en) | 2012-08-31 | 2015-09-22 | University Of North Texas Health Science Center At Fort Worth | Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy |
| RU2494733C1 (ru) | 2012-10-16 | 2013-10-10 | Всеволод Иванович Киселев | Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты) |
| US9517249B2 (en) | 2012-11-26 | 2016-12-13 | Access Business Group International Llc | Antioxidant dietary supplement and related method |
| CN102949375B (zh) * | 2012-11-28 | 2015-04-08 | 厦门大学附属第一医院 | 一种盐酸小檗碱固体脂质纳米制剂及其制备方法 |
| WO2014135967A1 (en) | 2013-03-06 | 2014-09-12 | Capsugel Belgium Nv | Curcumin solid lipid particles and methods for their preparation and use |
| AU2014354599A1 (en) | 2013-11-27 | 2016-06-09 | Research Foundation Of The City University Of New York | Activity enhancing curcumin compositions and methods of use |
| WO2015095576A1 (en) | 2013-12-18 | 2015-06-25 | Signpath Pharma, Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| CN103784421B (zh) * | 2014-02-27 | 2016-04-27 | 哈尔滨医科大学 | 载姜黄素和胡椒碱的固体脂质纳米粒及其制备方法 |
| ES2942132T3 (es) | 2014-06-03 | 2023-05-30 | Signpath Pharma Inc | Efecto protector de DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG y LYSOPC frente a fármacos que provocan canalopatías |
| WO2015186144A2 (en) * | 2014-06-07 | 2015-12-10 | Laila Pharmaceuticals Pvt. Ltd. | Method of inhibition of beta-secretase by using bis-o-demethylcurcumin for the prevention, management and treatment of neurodegenerative diseases |
| WO2016077454A1 (en) * | 2014-11-11 | 2016-05-19 | Verdure Sciences | Stable solid lipid particle composition for improved bioavailability of lipophilic compounds for age-related diseases |
| EP3226845A1 (en) | 2014-12-04 | 2017-10-11 | Capsugel Belgium NV | Lipid multiparticulate formulations |
| WO2016097914A1 (en) | 2014-12-15 | 2016-06-23 | Aurea Biolabs Private Limited | A process for preparation of bioavailable white curcumin - a unique blend of hydrogenated curcuminoids |
| US11318110B2 (en) | 2015-08-28 | 2022-05-03 | Caliway Biopharmaceuticals Co., Ltd. | Pharmaceutical composition for reducing local fat and uses thereof |
| JP7063803B2 (ja) * | 2015-08-28 | 2022-05-09 | カリウェイ バイオファーマシューティカルズ カンパニー リミテッド | 局所脂肪の減少に用いる医薬組成物およびその用途 |
| US20170071901A1 (en) * | 2015-09-15 | 2017-03-16 | Guodong Zhang | Methods and formulations for increasing chemical stability and biological activity of phenolic compounds |
| WO2017095138A1 (en) * | 2015-11-30 | 2017-06-08 | Gil Medical Center | Curcumin-containing lipid nanoparticle complex comprising ginsenosides |
| AU2017257496B2 (en) | 2016-04-27 | 2020-05-07 | Signpath Pharma, Inc. | Prevention of drug-induced atrio-ventricular block |
| US10076552B2 (en) | 2016-08-09 | 2018-09-18 | DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. | Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof |
| KR20190040305A (ko) * | 2016-08-26 | 2019-04-17 | 칼리웨이 바이오파마슈티칼스 코., 엘티디. | 체중 감소를 위한 피하 주사제 및 그의 용도 |
| EP3290026A1 (en) | 2016-09-06 | 2018-03-07 | Athenion AG | Method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents |
| WO2018083677A1 (en) * | 2016-11-07 | 2018-05-11 | Akay Flavours & Aromatics Pvt. Ltd. | Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof |
| EP3536332A1 (en) | 2018-03-07 | 2019-09-11 | Athenion AG | Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents |
| EP3870201A4 (en) | 2018-10-23 | 2022-08-03 | Stabicon Life Sciences Pvt. Ltd. | FORMULATION COMPRISING WATER SOLUBLE PARTICLES OF A NON-CURCUMINOID AND A CURCUMINOID |
| CN109549924B (zh) * | 2018-11-21 | 2021-05-11 | 四川大学华西医院 | Sklb023混合胶束及其制备方法和用途 |
| US20220151945A1 (en) * | 2018-11-26 | 2022-05-19 | Registrar, Panjab University Chandigarh | Solid lipid nanoparticles of curcumin |
| CA3127506A1 (en) | 2019-02-11 | 2020-08-20 | Joseph Halstead | Therapeutically administrable high dose non-aqueous curcuminoid solutions |
| US20220178936A1 (en) * | 2019-04-14 | 2022-06-09 | The Regents Of The University Of California | A sensitive lc-ms assay to measure curcuminoids in complex biological samples |
| BR112022010900A2 (pt) * | 2019-12-03 | 2022-09-06 | Omniactive Health Tech Limited | Composições de curcumina para osteoartrite e bem-estar da articulação |
| CN111388676A (zh) * | 2020-02-11 | 2020-07-10 | 湖南中茂生物科技有限公司 | 一种提高姜黄素水溶性的组合物及其在制备治疗老年痴呆的复方中的应用 |
| US12390504B2 (en) * | 2020-03-26 | 2025-08-19 | Verdure Sciences, Inc. | Polyphenol blend of curcumin extract and pomegranate extract and methods of improving immune response |
| CN111568882A (zh) * | 2020-06-09 | 2020-08-25 | 复旦大学附属中山医院青浦分院 | 一种复方姜黄素纳米粒和制备方法及其应用 |
| US12208067B2 (en) | 2020-06-26 | 2025-01-28 | Pharmako Biotechnologies Pty Ltd. | Liquid dispersible curcuminoid compositions and methods of improving cognitive function |
| CN112315953B (zh) * | 2020-11-06 | 2023-03-07 | 中国海洋大学 | 一种姜黄素酯在改善急性肾损伤制品中的应用 |
| WO2022165539A1 (en) * | 2021-02-01 | 2022-08-04 | The Board Of Trustees Of The Leland Stanford Junior University | Amyloid-binding peptoids with broad-spectrum antiviral, antibacterial, and antifungal activity |
| US20230190937A1 (en) * | 2021-11-05 | 2023-06-22 | Cornell University | Iron complexes of esterified derivatives of natural products, and methods of use |
| EP4186497A1 (en) | 2021-11-26 | 2023-05-31 | Dorian Bevec | Alpha lipoic acid, epigallocatechin 3-gallate, and curcumin as a medicament for the treatment of arthritis or sars-cov-2 infection |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4263333A (en) * | 1979-09-12 | 1981-04-21 | General Foods Corporation | Curcumin-metal color complexes |
| KR920004818B1 (ko) * | 1989-11-28 | 1992-06-18 | 태평양화학 주식회사 | 세포 보호제 조성물 |
| US6979441B2 (en) * | 1998-09-16 | 2005-12-27 | Wilson T Crandall | Method for topical treatment of carpal tunnel syndrome |
| US20040266883A1 (en) * | 1999-10-27 | 2004-12-30 | Yale University | Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| JP4179494B2 (ja) * | 2001-10-23 | 2008-11-12 | 株式会社カネカ | ペルオキシソーム増殖剤応答性受容体リガンド剤 |
| US20050222250A1 (en) * | 2002-04-16 | 2005-10-06 | Mohiaddin Rezvani | Curcumin for the prevention and/or treatment of tissue damage |
| US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
| AU2003270283A1 (en) * | 2002-10-01 | 2004-04-23 | Dr. Andre Rieks - Labor Fur Enzymtechnologie Gmbh | Novel curcumin/tetrahydrocurcumin derivatives for using in cosmetics, pharmaceuticals and for nutrition |
| ITMI20022323A1 (it) | 2002-10-31 | 2004-05-01 | Maria Rosa Gasco | Composizioni farmaceutiche atte al trattamento di malattie oftalmiche. |
| US7083813B2 (en) * | 2002-11-06 | 2006-08-01 | The Quigley Corporation | Methods for the treatment of peripheral neural and vascular ailments |
| WO2004080396A2 (en) * | 2003-03-07 | 2004-09-23 | The University Of Texas Md Anderson Cancer Center | Liposomal curcumin for treatment of cancer |
| US20080103213A1 (en) * | 2004-03-05 | 2008-05-01 | Board Of Regents, The University Of Texas System | Liposomal curcumin for treatment of neurofibromatosis |
| US20060045928A1 (en) * | 2004-08-31 | 2006-03-02 | Seiri Oshiro | Composition containing herbal medicine component for promoting absorption and production method thereof |
| US20060228403A1 (en) * | 2005-04-12 | 2006-10-12 | Zimmerman Karl A | Nutritional supplements for cardiovascular health |
| EP1837030A1 (en) * | 2006-03-09 | 2007-09-26 | INDENA S.p.A. | Phospholipid complexes of curcumin having improved bioavailability |
-
2007
- 2007-03-06 PL PL07752521T patent/PL1993365T3/pl unknown
- 2007-03-06 US US12/225,005 patent/US9192644B2/en active Active
- 2007-03-06 ES ES07752521T patent/ES2427216T3/es active Active
- 2007-03-06 WO PCT/US2007/005829 patent/WO2007103435A2/en active Application Filing
- 2007-03-06 EP EP07752521.0A patent/EP1993365B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1993365A4 (en) | 2010-04-07 |
| WO2007103435A3 (en) | 2007-10-25 |
| ES2427216T3 (es) | 2013-10-29 |
| US20090324703A1 (en) | 2009-12-31 |
| EP1993365A2 (en) | 2008-11-26 |
| EP1993365B1 (en) | 2013-05-08 |
| WO2007103435A2 (en) | 2007-09-13 |
| US9192644B2 (en) | 2015-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1993365T3 (pl) | Preparaty z biodostępnych kurkuminoidów do leczenia choroby alzheimera oraz innych zaburzeń powiązanych z wiekiem | |
| IL264736B (en) | Pharmaceutical preparations containing zonisamide for use in the treatment of diseases related to Alzheimer's disease | |
| EP2091566A4 (en) | COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES | |
| EP2151435A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| EP1940373B8 (en) | 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease | |
| ZA201002751B (en) | Compositions for treating parkinson's disease | |
| EP2382176A4 (en) | USE OF CURCUMIN ANALOGUES CONTAINING NITROGEN FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| IL194789A0 (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
| GB2443287B (en) | Methods, compositions and formulations for the treatment of thyroid eye disease | |
| IL177015A0 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
| PT2197883E (pt) | Derivados de catecolamina úteis para o tratamento da doença de parkinson | |
| EP1809601A4 (en) | COMPOUNDS FOR ALZHEIMER'S DISEASE | |
| EP2306824A4 (en) | IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER | |
| IL185300A0 (en) | New pharmaceutical compositions useful in the treatment of parkinson's disease | |
| IL186022A0 (en) | Dermatological compositions and salts for the treatment of dermatological diseases | |
| EP2010215A4 (en) | METHOD AND COMPOSITIONS FOR TREATING MORBUS CROHN | |
| EP2214488A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS | |
| IL184849A0 (en) | Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation | |
| EP2059238A4 (en) | THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS | |
| HU0500145D0 (en) | Composition for the treatment of oral diseases | |
| EP2099476A4 (en) | METHODS OF TREATING ALZHEIMER'S DISEASE | |
| EP1863510A4 (en) | METHOD FOR TREATING PARKINSON DISEASE | |
| TWI341204B (en) | Composition and method for prevention and treatment of alzheimer's disease | |
| EP1858557A4 (en) | METHODS AND COMPOSITIONS FOR MODULATING BODY WEIGHT AND TREATING WEIGHT RELATED DISORDERS AND DISEASES | |
| ZA200708279B (en) | Dermatological compositions and salts for the treatment of dermatological diseases |